Washington Trust Bank lowered its position in CVS Health Corporation (NYSE:CVS) by 25.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,803 shares of the pharmacy operator’s stock after selling 1,650 shares during the period. Washington Trust Bank’s holdings in CVS Health Corporation were worth $386,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of CVS. Fulton Bank N.A. increased its stake in shares of CVS Health Corporation by 82.4% in the first quarter. Fulton Bank N.A. now owns 31,936 shares of the pharmacy operator’s stock worth $2,507,000 after buying an additional 14,432 shares during the period. Trust Co increased its stake in shares of CVS Health Corporation by 5.2% in the fourth quarter. Trust Co now owns 34,185 shares of the pharmacy operator’s stock worth $2,697,000 after buying an additional 1,677 shares during the period. Boltwood Capital Management increased its stake in shares of CVS Health Corporation by 12.7% in the first quarter. Boltwood Capital Management now owns 8,675 shares of the pharmacy operator’s stock worth $680,000 after buying an additional 975 shares during the period. Cardinal Capital Management Inc. increased its stake in shares of CVS Health Corporation by 13,788.8% in the first quarter. Cardinal Capital Management Inc. now owns 134,305 shares of the pharmacy operator’s stock worth $10,543,000 after buying an additional 133,338 shares during the period. Finally, Hills Bank & Trust Co. increased its stake in shares of CVS Health Corporation by 0.6% in the first quarter. Hills Bank & Trust Co. now owns 45,870 shares of the pharmacy operator’s stock worth $3,601,000 after buying an additional 258 shares during the period. Institutional investors and hedge funds own 82.31% of the company’s stock.

Shares of CVS Health Corporation (NYSE CVS) traded up 0.01% on Thursday, reaching $79.26. 1,542,701 shares of the company’s stock were exchanged. The firm’s 50 day moving average price is $78.82 and its 200-day moving average price is $78.95. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $98.44. The company has a market capitalization of $80.57 billion, a P/E ratio of 15.79 and a beta of 0.91.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The company had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $45.36 billion. During the same quarter last year, the company posted $1.32 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, equities analysts anticipate that CVS Health Corporation will post $5.88 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Thursday, August 3rd. Shareholders of record on Monday, July 24th were issued a dividend of $0.50 per share. The ex-dividend date was Thursday, July 20th. This represents a $2.00 annualized dividend and a yield of 2.52%. CVS Health Corporation’s dividend payout ratio (DPR) is presently 39.92%.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/08/17/washington-trust-bank-sells-1650-shares-of-cvs-health-corporation-cvs.html.

A number of equities research analysts have recently commented on CVS shares. Tigress Financial started coverage on shares of CVS Health Corporation in a report on Thursday, April 27th. They set a “buy” rating for the company. Vetr downgraded shares of CVS Health Corporation from a “buy” rating to a “hold” rating and set a $85.78 price target for the company. in a report on Thursday, April 27th. Evercore ISI reiterated an “outperform” rating and set a $88.00 price target (up from $87.00) on shares of CVS Health Corporation in a report on Wednesday, May 3rd. ValuEngine downgraded shares of CVS Health Corporation from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Finally, Jefferies Group LLC restated a “hold” rating and issued a $82.00 target price on shares of CVS Health Corporation in a report on Friday, June 9th. Eight research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $91.48.

In other CVS Health Corporation news, CFO David M. Denton sold 230,510 shares of the stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the transaction, the chief financial officer now owns 176,983 shares in the company, valued at $14,158,640. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Helena Foulkes sold 20,332 shares of the stock in a transaction that occurred on Monday, June 19th. The shares were sold at an average price of $76.98, for a total value of $1,565,157.36. Following the transaction, the executive vice president now owns 59,300 shares in the company, valued at approximately $4,564,914. The disclosure for this sale can be found here. In the last quarter, insiders have sold 271,175 shares of company stock worth $21,632,597. Corporate insiders own 0.61% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.